ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸

HNGE // Hinge Health Inc.

FA <GO> NYSE CIK 0001673743 ↗
Technology • EDP Services
$116.90 ▲ +1.62 (+1.41%)
MKT CAP: $9.43B • VOL: 2.14M
HNGE // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
LINE ITEM (USD / %)
FY 2025
FILED 2025-12-31
FY 2024
FILED 2024-12-31
FY 2023
FILED 2023-12-31
Revenue (Total Sales) $587.9M $390.4M $292.7M
YoY Revenue Growth % +50.6% +33.4% —
Gross Profit $468.2M $299.9M $128.8M
Gross Margin % 79.6% 76.8% 44.0%
Research & Development (R&D) — — —
Operating Income (EBIT) -$546.4M -$31.9M -$130.5M
Operating Margin % -92.9% -8.2% -44.6%
Net Income (GAAP) -$528.3M -$11.9M -$108.1M
EBITDA (Normalized) -$545.8M -$31.1M -$120.0M
Diluted EPS ($/sh) — — —
Operating Cash Flow (OCF) $171.4M $49.0M -$63.9M
Capital Expenditures (CapEx) $708.0K $1.0M $13.2M
Free Cash Flow (FCF) $170.7M $48.0M -$77.1M
FCF Margin % 29.0% 12.3% -26.3%
Return on Invested Capital (ROIC %) -45.0% -45.0% -3.3%
Cash & Short-Term Equivalents $208.0M $300.8M $570.7M
Total Debt (Short + Long Term) $164.8M $115.5M $1.21B
Total Stockholders' Equity $178.7M -$434.6M $2.49B